Ramose Laboratories Private Limited - Due diligence report

A 360° intelligence report on Ramose Laboratories Private Limited: trust score, financial health, credit view, compliance, directors, growth…

2002-10-10 Delhi, Delhi Active Unlisted Active Compliant
Share
Connect MCP
RL Ramose Laboratories Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Ramose Laboratories Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
92/100
Trust Score
Low Risk

Ramose Laboratories Private Limited is assessed as Low Risk with a Trust Score of 92/100. Ramose Laboratories Private Limited is an active private limited indian non-government company incorporated in 2002, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 11 Aug 2026 from the latest processed filings. Ramose Laboratories Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
92/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 93/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 1 court forum(s).
  • 4 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
SUNIL KUMAR SHAHI 01234567 Director 01/04/2018 6 yrs Approved
ABHAYA KUMAR 01234567 Director 01/04/2018 6 yrs Approved
PUSHPA DEVI THAKUR 01234567 Director 01/04/2018 6 yrs Approved
ANIL KUMAR 01234567 Director 01/04/2018 6 yrs Approved
SHABNAM SINHA 01234567 Director 01/04/2018 6 yrs Approved
Sanjeev Kumar 01234567 Director 01/04/2018 6 yrs Approved
Bablu Kumar 01234567 Director 01/04/2018 6 yrs Approved
Amit Kumar 01234567 Director 01/04/2018 6 yrs Approved
  • 8 directors on the board.
  • No disqualified or deactivated DINs.
  • 3 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 1 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 80
Growth signals & trust indicators
Operating for 23+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
3 director exits within 2 years.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence89/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment90/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view72/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
29 Sep 2025
Director ceased
Sanjeev Kumar
Director ceased
Bablu Kumar
Director ceased
Amit Kumar
17 Jul 2025
Director appointed
Amit Kumar (Director)
31 Mar 2025
Latest balance sheet
Filed with ROC
17 Jun 2024
Director appointed
Sanjeev Kumar (Director)
Director appointed
Bablu Kumar (Director)
31 Mar 2021
Share transfer (FY 2021)
2500.00000000 shares to ANIL KUMAR
21 Mar 2016
Securities allotted
200000 Equity Shares - 40.00 Lakh raised
15 Jul 2010
Director appointed
SHABNAM SINHA (Director)
25 May 2007
Director ceased
SHABNAM SINHA
28 Dec 2002
Director appointed
SUNIL KUMAR SHAHI (Director)
Director appointed
ABHAYA KUMAR (Director)
10 Oct 2002
Incorporated
Registered with Roc Delhi
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
8 active director(s) / partner(s); board looks stable and experienced.
4 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Sports Biotech Nutrition Private Limited U74999DL2017PTC322234 New Delhi, Delhi, India
Lilanand Trading Co. Pvt Ltd U24298WB1963PTC025743 Kolkata, West Bengal, India
Casuarina Confectioners Private Limited U15411WB1994PTC065818 Kolkata, West Bengal, India
Crt Comptex Private Limited U31902PN2012PTC145548 Pune, Maharashtra, India
Sofpark Infra Mgmt Services Private Limited U72501UP2017PTC096236 Meerut, Uttar Pradesh, India
Technoflex Steel India Private Limited U28999MP2020PTC052604 Indore, Madhya Pradesh, India
Anandi Electricals And Electronics Private Limited U31909DL2003PTC119332 Delhi, Delhi, India
Cy Cosmetics Private Limited U93090DL2018PTC333321 Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Ramose Laboratories Private Limited before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Ramose Laboratories Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 40/100, margin trends, ownership structure and peer set for Ramose Laboratories Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 92/100, distress signals and MSME payment-delay disclosures - know whether Ramose Laboratories Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Ramose Laboratories Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Ramose Laboratories Private Limited an active company?

Ramose Laboratories Private Limited has MCA status “Active” with a compliance score of 93/100 (Low Risk).

Is Ramose Laboratories Private Limited financially healthy?

Ramose Laboratories Private Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Ramose Laboratories Private Limited?

Its overall Trust Score is 92/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Ramose Laboratories Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 8 active director(s) are on record.

Does Ramose Laboratories Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Ramose Laboratories Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).

Is it risky to lend to Ramose Laboratories Private Limited?

Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.